Member-only story
The Best of the Coronavirus Blog This Week
There’s really never a dull moment in a pandemic, and this week was filled with Covid-19 news. Here are three stories from Medium’s Coronavirus Blog to get you caught up as you head into the weekend.
Your Friday vaccine update
Pfizer won’t seek vaccine approval before November. The CEO of the company said on Friday that Pfizer will not apply for emergency authorization of its Covid-19 vaccine before the third week of November, ruling out a vaccine before Election Day.
Big Tech cracks down on anti-vaccination. On Tuesday, Facebook said it would ban anti-vaccination ads from its platform — a significant about-face for the company, which has avoided censoring controversial content in the past. YouTube followed suit on Wednesday, saying it would remove any videos containing misinformation about Covid-19 vaccines.
Russia approves another vaccine for limited use. On Wednesday, Russia announced that it had granted regulatory approval for a vaccine from the Vector Institute called EpiVacCorona, bringing the number of limited-use vaccines approved by the country to two. Russia, controversially, does not require the same rigorous three-phase trials required by the United States before granting approval to a vaccine.
